OverviewSuggest Edit

GlaxoSmithKline is a science-led global healthcare company on a mission to help people do more, feel better and live longer. The Company has three businesses that research, develop and manufacture pharmaceutical medicines, vaccines and consumer healthcare products. GlaxoSmithKline manufactures products for major disease areas such as asthma, cancer, infections, diabetes and mental health. 


... Show more
TypePublic
Founded2000
HQBrentford, GB
Websitegsk.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Feb 2019)98,462
Job Openings1,498
Revenue (FY, 2017)£30.2 B(+9%)
Share Price (Jul 2018)$41.1

Key People/Management at GlaxoSmithKline

Emma Walmsley

Emma Walmsley

Chief Executive Officer of GSK
Simon Dingemans

Simon Dingemans

CFO
Hal Barron

Hal Barron

Chief Scientific Officer and President, R&D
Roger Connor

Roger Connor

President, Global Vaccines
James Ford

James Ford

Senior Vice President and General Counsel
Nick Hirons

Nick Hirons

Senior Vice President, Global Ethics and Compliance
Show more

GlaxoSmithKline Office Locations

GlaxoSmithKline has an office in Brentford
Brentford, GB (HQ)
980 Great West Rd
Show all (1)
Report incorrect company information

GlaxoSmithKline Financials and Metrics

GlaxoSmithKline Revenue

Embed Graph
View revenue for all periods
GlaxoSmithKline's revenue was reported to be £30.19 b in FY, 2017 which is a 8.2% increase from the previous period.
GBP

Revenue (Q1, 2018)

7.2b

Gross profit (Q1, 2018)

4.8b

Gross profit margin (Q1, 2018), %

66.9%

Net income (Q1, 2018)

759.0m

EBIT (Q1, 2018)

1.2b

Market capitalization (11-Jul-2018)

101.9b

Closing stock price (11-Jul-2018)

41.1

Cash (31-Mar-2018)

4.0b

EV

115.4b
GlaxoSmithKline's current market capitalization is $101.9 b.
Annual
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2016FY, 2017

Revenue

18.1b20.5b21.2b21.4b20.4b21.7b23.2b22.7b26.5b27.9b30.2b

Revenue growth, %

17%8%

Cost of goods sold

4.0b4.7b4.6b4.5b4.3b4.8b5.0b5.3b8.6b9.3b10.3b

Gross profit

14.1b15.8b16.6b16.9b16.0b16.9b18.2b17.4b17.9b18.6b19.8b
Quarterly
GBPQ1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

7.4b7.3b7.8b7.2b

Cost of goods sold

2.5b2.6b2.7b2.4b

Gross profit

4.9b4.7b5.2b4.8b

Gross profit Margin, %

66%64%66%67%
Annual
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2016FY, 2017

Cash

1.3b716.0m1.1b962.0m1.2b4.2b2.0b3.4b5.5b4.9b3.8b

Accounts Receivable

3.3b3.6b3.5b3.7b3.8b4.4b4.4b4.6b4.0b6.0b6.0b

Inventories

2.3b2.1b2.1b2.1b2.2b2.2b2.4b3.1b3.9b5.1b5.6b

Current Assets

11.3b10.0b10.7b12.6b13.6b13.2b11.0b13.6b15.2b16.7b15.9b
Quarterly
GBPQ1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

4.5b4.0b4.7b4.0b

Accounts Receivable

6.2b6.2b6.5b6.1b

Inventories

5.4b5.7b5.7b5.7b

Current Assets

16.8b16.4b17.7b16.4b
Annual
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2016FY, 2017

Net Income

4.3b3.2b4.0b4.6b4.4b4.8b5.5b5.3b5.6b1.1b2.2b

Depreciation and Amortization

2.0b2.9b

Inventories

70.0m(461.0m)

Accounts Payable

96.0m11.0m
Quarterly
GBPQ1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

1.2b1.1b2.5b759.0m

Cash From Operating Activities

1.1b2.2b4.0b863.0m

Purchases of PP&E

(260.0m)(639.0m)(1.0b)(258.0m)

Cash From Investing Activities

(199.0m)(646.0m)(1.1b)(371.0m)
GBPY, 2018

EV/EBIT

93 x

EV/CFO

133.7 x

Debt/Equity

4.9 x

Debt/Assets

0.3 x

Financial Leverage

15.6 x
Show all financial metrics

GlaxoSmithKline Operating Metrics

GlaxoSmithKline's Unique Visitors was reported to be 1.8 m in FY, 2015.
FY, 2014FY, 2015FY, 2016FY, 2017

Manufacturing Facilities

57 54 87

Markets

150 150 150

Unique Visitors

1.80 m

Volume of Medicines Produced

1.90 b
Show all operating metrics

GlaxoSmithKline Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
TESARODecember 04, 2018$5.10 b
NovartisMarch 27, 2018$13 b

GlaxoSmithKline Revenue Breakdown

Embed Graph

GlaxoSmithKline revenue breakdown by business segment: 25.7% from Consumer Healthcare, 17.1% from Vaccines and 57.2% from Global Pharmaceuticals

GlaxoSmithKline revenue breakdown by geographic segment: 59.6% from International, 37.3% from US and 3.1% from Other

Report incorrect company information

GlaxoSmithKline Online and Social Media Presence

Embed Graph
Report incorrect company information

GlaxoSmithKline Blogs

GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts.

GSK announces succession plan to appoint new Chairman

GSK announces that Sir Philip Hampton has informed the Board of his intention to step down as non-executive Chairman.

Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine

GSK and Medicines for Malaria Venture (MMV) today announced the publication of positive results from two phase III studies of single-dose tafenoquine for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria in The New England Journal of Medicine.

Juluca (dolutegravir/rilpivirine), the first single pill, 2-drug regimen, for the maintenance treatment of HIV, granted marketing approval by Japan Ministry of Health, Labour and Welfare

The Ministry of Health, Labour and Welfare (MHLW) has approved Juluca Combination Tablets for the maintenance treatment of human immunodeficiency virus type 1 (HIV-1) infection.
Show more

GlaxoSmithKline Company Life and Culture

Report incorrect company information

GlaxoSmithKline Frequently Asked Questions

  • When was GlaxoSmithKline founded?

    GlaxoSmithKline was founded in 2000.

  • Who are GlaxoSmithKline key executives?

    GlaxoSmithKline's key executives are Emma Walmsley, Simon Dingemans and Hal Barron.

  • How many employees does GlaxoSmithKline have?

    GlaxoSmithKline has 98,462 employees.

  • What is GlaxoSmithKline revenue?

    Latest GlaxoSmithKline annual revenue is £30.2 b.

  • What is GlaxoSmithKline revenue per employee?

    Latest GlaxoSmithKline revenue per employee is £306.6 k.

  • Who are GlaxoSmithKline competitors?

    Competitors of GlaxoSmithKline include Eli Lilly, Pfizer and Merck.

  • Where is GlaxoSmithKline headquarters?

    GlaxoSmithKline headquarters is located at 980 Great West Rd, Brentford.

  • Where are GlaxoSmithKline offices?

    GlaxoSmithKline has an office in Brentford.

  • How many offices does GlaxoSmithKline have?

    GlaxoSmithKline has 1 office.